The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

nextgenjane.com

Total Raised

$14.34M

Investors Count

16

NextGen Jane Funding, NextGen Jane Valuation & NextGen Jane Revenue

5 Fundings

NextGen Jane's latest funding round was a Debt for $1.5M on June 10, 2022.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/10/2022

Debt

$1.5M

Undisclosed Investors

0

FY undefined

1

2/23/2022

Grant

$99M

0

FY undefined

10

4/1/2019

Series A

$99M

0

FY undefined

10

3/10/2016

Seed

$99M

0

FY undefined

10

12/9/2015

Convertible Note

$99M

0

FY undefined

10

Date

6/10/2022

2/23/2022

4/1/2019

3/10/2016

12/9/2015

Round

Debt

Grant

Series A

Seed

Convertible Note

Amount

$1.5M

$99M

$99M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

NextGen Jane Investors

16 Investors

NextGen Jane has 16 investors. National Institutes of Health invested in NextGen Jane's Grant funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

2/23/2022

2/23/2022

1
Grant

Government

Maryland

4/1/2019

4/1/2019

1
Series A

Angel Investor (Individual)

United States

4/1/2019

4/1/2019

1
Series A

Angel Investor (Individual)

00/00/0000

00/00/0000

Kacey Fitzpatrick

Subscribe to see more

Angel Investor (Individual)

00/00/0000

00/00/0000

Steve Quake

Subscribe to see more

Angel Investor (Individual)

First funding

2/23/2022

4/1/2019

4/1/2019

00/00/0000

00/00/0000

Last Funding

2/23/2022

4/1/2019

4/1/2019

00/00/0000

00/00/0000

Investor

Kacey Fitzpatrick

Steve Quake

Rounds

1
Grant
1
Series A
1
Series A

Subscribe to see more

Subscribe to see more

Board Seats

Type

Government

Angel Investor (Individual)

Angel Investor (Individual)

Angel Investor (Individual)

Angel Investor (Individual)

Location

Maryland

United States

You May Also Like

T
Temple Therapeutics

Temple Therapeutics is a pharmaceutical clinical development company with a global footprint, focused on diseases where abnormal tissue growth and dysfunction are common hallmarks and lead to fibrosis, pain, infertility, and cancers. The company was founded in 2020 and is based in Geleen, Netherlands.

DotLab Logo
DotLab

DotLab is developing a non-invasive test for endometriosis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.